Transport service
Our transport service gives you more control over your treatment journey and reduces the financial pressures and anxiety that come with navigating life with blood cancer.
We provide practical support including vouchers to reduce travel costs, to help you get to medical appointments in a way that suits you as well as information about other transport providers in your area.
Our transport service is always evolving to better meet the needs of the blood cancer community, an evolution proudly supported by Bridgestone and its network since 1986.
Types of support
- Vouchers: Fuel, Uber or taxi vouchers to ease the cost of travel.
- Community transport information: Details about other community transport providers in the area. This could include transport services for cancer treatment or related appointments.
- Subsidies: Patient accommodation and travel schemes in each Australian state and territory provide subsidies for some long-distance and interstate travel.
Eligibility and assessment process
People who need help travelling to blood cancer-related medical appointments in a capital city are eligible for the Leukaemia Foundation’s transport service.
Our support team will consider individual circumstances and preferences when assessing each request for support. This approach helps the Leukaemia Foundation to deliver flexible options and break down barriers which may prevent people accessing treatment when and where they need it.
How to apply
- Online: Fill out the Apply for support form. This can be completed by the person seeking transport assistance, a member of their care team or a Leukaemia Foundation healthcare professional.
- Phone: 1800 620 420 (free call).
Please note, if you are seeking transport assistance, our team will need to confirm your diagnosis with your treating team.
Apply for support
Each request is processed within three business days. If your enquiry is urgent, please call us on 1800 620 420.
Feedback
We are committed to continuously improving our services to better meet your needs. Please share your experience with our transport service.
Need help?
Blood Cancers A-Z
A
AA secondary amyloidosis
Acute lymphoblastic leukaemia ALL
Acute myeloid leukaemia AML
Acute myelomonocytic leukaemia AMML
Acute promyelocytic leukaemia APML
Afib mutated fibrinogen alpha chain amyloidosis
AL systemic amyloidosis
Amyloidosis
Aplastic anaemia AA
ATTR familial amyloidotic polyneuropathy
ATTR wild type senile amyloidosis
B
Biphenotypic leukaemia
Bisphosphonates myeloma
C
Chronic lymphocytic leukaemia CLL
Chronic myeloid leukaemia CML
H
Hairy cell leukaemia
Hodgkin lymphoma
I
IgA myeloma
IgG myeloma
J
Juvenile myelomonocytic leukaemia JMML
L
Langerhans Cell Histiocytosis LCH
Leukaemia
Light chain myeloma
Lymphocyte depleted HL
Lymphocyte rich HL
Lymphoma
M
MDS with biallelic TP53 inactivation MDS-biTP53
MDS with fibrosis
MDS with hypoplastic MDS-h
MDS with increased blasts MDS-IB1
MDS with increased blasts MDS-IB2
MDS with low blasts MDS-LB
MDS with low blasts and isolated 5q deletion MDS-5q
MDS with low blasts and SF3B1 mutation MDS-SF3B1
Mixed cellularity HL
Monoclonal gammopathy of unknown significance MGUS
MPN Chronic eosinophilic leukaemia CEL
MPN Chronic myelomonocytic leukaemia CMML
MPN Chronic myelomonocytic leukaemia CMML
MPN Chronic neutrophilic leukaemia CNL
MPN Essential thrombocythaemia ET
MPN Polycythaemia Rubra vera PV
MPN Primary myelofibrosis MF
MPN Systemic mastocytosis SM
Multiple myeloma
Myelodysplasia Myelodysplastic neoplasms MDS
Myeloma
Myeloid sarcoma localised leukaemia
Myeloproliferative neoplasms MPN
N
NHL Adult T-Cell leukaemic ATLL
NHL Anaplastic large cell ALCL
NHL Burkitt’s
NHL Cutaneous T-Cell
NHL Diffuse large B-cell DLBCL
NHL Double hit DHL
NHL Follicular
NHL Lymphoplasmacytic Waldenstrom’s macroglobulinaemia WM
NHL MALT
NHL Mantle cell
NHL Marginal zone
NHL Peripheral T-Cell
NHL Primary cutaneous B-cell
NHL Primary mediastinal B-cell PMBCL
NHL Small lymphocytic SLL
NHL Subcutaneous panniculitis-like T-Cell
NHL T-Lymphoblastic
NHL Waldenstroms macroglobulinaemia
Non-Hodgkin lymphoma
Nodular lymphocyte predominant HL
Nodular sclerosing HL
O
Osteosclerotic myeloma
P
Paroxysmal nocturnal haemoglobinuria
Plasmacytoma localised myeloma
POEMS syndrome
R
Richter’s syndrome leukaemia
S
Smouldering indolent myeloma
Solitary plasmacytoma myeloma
Systemic mastocytosis